Renin_angiotensin_stable.sbml 194 KB
Newer Older
artenobot's avatar
artenobot committed
1
<?xml version='1.0' encoding='utf-8'?>
cylon-x's avatar
cylon-x committed
2
<sbml xmlns:bqbiol="http://biomodels.net/biology-qualifiers/" xmlns:bqmodel="http://biomodels.net/model-qualifiers/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" level="3" version="1" layout:required="false" xmlns="http://www.sbml.org/sbml/level3/version1/core" qual:required="true" xmlns:layout="http://www.sbml.org/sbml/level3/version1/layout/version1" xmlns:qual="http://www.sbml.org/sbml/level3/version1/qual/version1"><model id="model_id"><listOfCompartments><compartment constant="true" id="comp1" /></listOfCompartments><layout:listOfLayouts><layout:layout id="layout1"><layout:dimensions width="2600" height="2500" /><layout:listOfAdditionalGraphicalObjects><layout:generalGlyph layout:reference="csa4" layout:id="csa4_glyph"><layout:boundingBox><layout:position layout:x="865.0" layout:y="1600.0" /><layout:dimensions layout:height="120.0" layout:width="100.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="csa5" layout:id="csa5_glyph"><layout:boundingBox><layout:position layout:x="1000.0" layout:y="230.0" /><layout:dimensions layout:height="120.0" layout:width="100.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="csa9" layout:id="csa9_glyph"><layout:boundingBox><layout:position layout:x="520.0" layout:y="1170.0" /><layout:dimensions layout:height="120.0" layout:width="100.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa21" layout:id="sa21_glyph"><layout:boundingBox><layout:position layout:x="704.5" layout:y="748.5" /><layout:dimensions layout:height="33.0" layout:width="95.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa22" layout:id="sa22_glyph"><layout:boundingBox><layout:position layout:x="1614.5" layout:y="748.5" /><layout:dimensions layout:height="35.0" layout:width="110.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa23" layout:id="sa23_glyph"><layout:boundingBox><layout:position layout:x="702.5" layout:y="1003.5" /><layout:dimensions layout:height="33.0" layout:width="95.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa24" layout:id="sa24_glyph"><layout:boundingBox><layout:position layout:x="1614.5" layout:y="1003.5" /><layout:dimensions layout:height="35.0" layout:width="110.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa25" layout:id="sa25_glyph"><layout:boundingBox><layout:position layout:x="1148.0" layout:y="1655.0" /><layout:dimensions layout:height="40.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa26" layout:id="sa26_glyph"><layout:boundingBox><layout:position layout:x="660.0" layout:y="1658.0" /><layout:dimensions layout:height="40.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa27" layout:id="sa27_glyph"><layout:boundingBox><layout:position layout:x="1805.0" layout:y="1655.0" /><layout:dimensions layout:height="40.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa28" layout:id="sa28_glyph"><layout:boundingBox><layout:position layout:x="2190.0" layout:y="950.0" /><layout:dimensions layout:height="40.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa30" layout:id="sa30_glyph"><layout:boundingBox><layout:position layout:x="1290.0" layout:y="280.0" /><layout:dimensions layout:height="40.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa32" layout:id="sa32_glyph"><layout:boundingBox><layout:position layout:x="1897.0" layout:y="1223.5" /><layout:dimensions layout:height="35.0" layout:width="110.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa34" layout:id="sa34_glyph"><layout:boundingBox><layout:position layout:x="715.0" layout:y="230.0" /><layout:dimensions layout:height="40.0" layout:width="70.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa37" layout:id="sa37_glyph"><layout:boundingBox><layout:position layout:x="264.0" layout:y="413.5" /><layout:dimensions layout:height="25.0" layout:width="70.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa38" layout:id="sa38_glyph"><layout:boundingBox><layout:position layout:x="1015.5" layout:y="70.5" /><layout:dimensions layout:height="39.0" layout:width="69.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa39" layout:id="sa39_glyph"><layout:boundingBox><layout:position layout:x="2180.0" layout:y="781.5" /><layout:dimensions layout:height="37.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa40" layout:id="sa40_glyph"><layout:boundingBox><layout:position layout:x="900.0" layout:y="270.0" /><layout:dimensions layout:height="40.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa43" layout:id="sa43_glyph"><layout:boundingBox><layout:position layout:x="1560.0" layout:y="280.0" /><layout:dimensions layout:height="40.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa44" layout:id="sa44_glyph"><layout:boundingBox><layout:position layout:x="1844.0" layout:y="132.0" /><layout:dimensions layout:height="30.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa45" layout:id="sa45_glyph"><layout:boundingBox><layout:position layout:x="880.0" layout:y="159.5" /><layout:dimensions layout:height="35.0" layout:width="110.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa47" layout:id="sa47_glyph"><layout:boundingBox><layout:position layout:x="1000.0" layout:y="675.0" /><layout:dimensions layout:height="30.0" layout:width="60.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa48" layout:id="sa48_glyph"><layout:boundingBox><layout:position layout:x="1410.0" layout:y="890.0" /><layout:dimensions layout:height="30.0" layout:width="50.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa49" layout:id="sa49_glyph"><layout:boundingBox><layout:position layout:x="1452.5" layout:y="1163.5" /><layout:dimensions layout:height="33.0" layout:width="95.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa50" layout:id="sa50_glyph"><layout:boundingBox><layout:position layout:x="1535.0" layout:y="1655.0" /><layout:dimensions layout:height="40.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa51" layout:id="sa51_glyph"><layout:boundingBox><layout:position layout:x="1077.5" layout:y="1163.5" /><layout:dimensions layout:height="33.0" layout:width="95.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa54" layout:id="sa54_glyph"><layout:boundingBox><layout:position layout:x="1960.0" layout:y="167.0" /><layout:dimensions layout:height="30.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa56" layout:id="sa56_glyph"><layout:boundingBox><layout:position layout:x="1113.0" layout:y="1805.75" /><layout:dimensions layout:height="35.0" layout:width="150.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa61" layout:id="sa61_glyph"><layout:boundingBox><layout:position layout:x="1113.0" layout:y="2041.5" /><layout:dimensions layout:height="35.0" layout:width="150.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa62" layout:id="sa62_glyph"><layout:boundingBox><layout:position layout:x="695.25" layout:y="1296.75" /><layout:dimensions layout:height="35.0" layout:width="110.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa63" layout:id="sa63_glyph"><layout:boundingBox><layout:position layout:x="695.5" layout:y="1436.0" /><layout:dimensions layout:height="35.0" layout:width="110.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa64" layout:id="sa64_glyph"><layout:boundingBox><layout:position layout:x="526.0" layout:y="1323.0" /><layout:dimensions layout:height="40.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa65" layout:id="sa65_glyph"><layout:boundingBox><layout:position layout:x="525.0" layout:y="1470.0" /><layout:dimensions layout:height="40.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa66" layout:id="sa66_glyph"><layout:boundingBox><layout:position layout:x="382.0" layout:y="809.5" /><layout:dimensions layout:height="41.0" layout:width="116.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa69" layout:id="sa69_glyph"><layout:boundingBox><layout:position layout:x="393.5" layout:y="1685.5" /><layout:dimensions layout:height="29.0" layout:width="113.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa70" layout:id="sa70_glyph"><layout:boundingBox><layout:position layout:x="1048.5" layout:y="1725.5" /><layout:dimensions layout:height="29.0" layout:width="113.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa71" layout:id="sa71_glyph"><layout:boundingBox><layout:position layout:x="463.5" layout:y="492.0" /><layout:dimensions layout:height="36.0" layout:width="43.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa73" layout:id="sa73_glyph"><layout:boundingBox><layout:position layout:x="1475.0" layout:y="166.5" /><layout:dimensions layout:height="40.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa77" layout:id="sa77_glyph"><layout:boundingBox><layout:position layout:x="1985.0" layout:y="1655.0" /><layout:dimensions layout:height="40.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa79" layout:id="sa79_glyph"><layout:boundingBox><layout:position layout:x="982.7894736842104" layout:y="1655.2894736842104" /><layout:dimensions layout:height="40.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa94" layout:id="sa94_glyph"><layout:boundingBox><layout:position layout:x="1698.0" layout:y="1655.0" /><layout:dimensions layout:height="40.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa95" layout:id="sa95_glyph"><layout:boundingBox><layout:position layout:x="1602.5" layout:y="129.5" /><layout:dimensions layout:height="33.0" layout:width="95.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa96" layout:id="sa96_glyph"><layout:boundingBox><layout:position layout:x="1602.5" layout:y="209.5" /><layout:dimensions layout:height="33.0" layout:width="95.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa98" layout:id="sa98_glyph"><layout:boundingBox><layout:position layout:x="1430.0" layout:y="280.0" /><layout:dimensions layout:height="40.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa100" layout:id="sa100_glyph"><layout:boundingBox><layout:position layout:x="2190.0" layout:y="1055.0" /><layout:dimensions layout:height="40.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa102" layout:id="sa102_glyph"><layout:boundingBox><layout:position layout:x="535.0" layout:y="1590.0" /><layout:dimensions layout:height="40.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa120" layout:id="sa120_glyph"><layout:boundingBox><layout:position layout:x="1390.0" layout:y="967.0" /><layout:dimensions layout:height="30.0" layout:width="50.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa121" layout:id="sa121_glyph"><layout:boundingBox><layout:position layout:x="920.0" layout:y="962.5" /><layout:dimensions layout:height="35.0" layout:width="110.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa122" layout:id="sa122_glyph"><layout:boundingBox><layout:position layout:x="808.0" layout:y="935.0" /><layout:dimensions layout:height="30.0" layout:width="60.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa132" layout:id="sa132_glyph"><layout:boundingBox><layout:position layout:x="1075.0" layout:y="366.5" /><layout:dimensions layout:height="25.0" layout:width="70.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa134" layout:id="sa134_glyph"><layout:boundingBox><layout:position layout:x="805.0" layout:y="221.875" /><layout:dimensions layout:height="26.25" layout:width="100.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa136" layout:id="sa136_glyph"><layout:boundingBox><layout:position layout:x="960.0" layout:y="590.0" /><layout:dimensions layout:height="30.0" layout:width="60.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa137" layout:id="sa137_glyph"><layout:boundingBox><layout:position layout:x="910.0" layout:y="640.0" /><layout:dimensions layout:height="30.0" layout:width="60.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa138" layout:id="sa138_glyph"><layout:boundingBox><layout:position layout:x="920.0" layout:y="855.5" /><layout:dimensions layout:height="35.0" layout:width="110.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa144" layout:id="sa144_glyph"><layout:boundingBox><layout:position layout:x="665.0" layout:y="795.0" /><layout:dimensions layout:height="30.0" layout:width="60.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa152" layout:id="sa152_glyph"><layout:boundingBox><layout:position layout:x="1262.0" layout:y="1650.0" /><layout:dimensions layout:height="40.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa156" layout:id="sa156_glyph"><layout:boundingBox><layout:position layout:x="1420.0" layout:y="1650.0" /><layout:dimensions layout:height="40.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa157" layout:id="sa157_glyph"><layout:boundingBox><layout:position layout:x="1113.0" layout:y="1982.75" /><layout:dimensions layout:height="35.0" layout:width="150.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa159" layout:id="sa159_glyph"><layout:boundingBox><layout:position layout:x="1952.5" layout:y="1730.0" /><layout:dimensions layout:height="30.0" layout:width="85.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa160" layout:id="sa160_glyph"><layout:boundingBox><layout:position layout:x="1390.0" layout:y="1429.5" /><layout:dimensions layout:height="35.0" layout:width="110.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa161" layout:id="sa161_glyph"><layout:boundingBox><layout:position layout:x="372.0" layout:y="1329.5" /><layout:dimensions layout:height="41.0" layout:width="116.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa162" layout:id="sa162_glyph"><layout:boundingBox><layout:position layout:x="526.4615384615386" layout:y="1415.1538461538462" /><layout:dimensions layout:height="40.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa165" layout:id="sa165_glyph"><layout:boundingBox><layout:position layout:x="1450.0" layout:y="87.5" /><layout:dimensions layout:height="35.0" layout:width="130.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa166" layout:id="sa166_glyph"><layout:boundingBox><layout:position layout:x="1121.5" layout:y="321.0" /><layout:dimensions layout:height="38.0" layout:width="147.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa168" layout:id="sa168_glyph"><layout:boundingBox><layout:position layout:x="985.0" layout:y="478.5" /><layout:dimensions layout:height="25.0" layout:width="70.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa169" layout:id="sa169_glyph"><layout:boundingBox><layout:position layout:x="1165.0" layout:y="388.5" /><layout:dimensions layout:height="25.0" layout:width="70.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa171" layout:id="sa171_glyph"><layout:boundingBox><layout:position layout:x="1113.0" layout:y="1862.75" /><layout:dimensions layout:height="35.0" layout:width="150.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa172" layout:id="sa172_glyph"><layout:boundingBox><layout:position layout:x="1114.0" layout:y="1922.5" /><layout:dimensions layout:height="35.0" layout:width="150.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa190" layout:id="sa190_glyph"><layout:boundingBox><layout:position layout:x="1340.0" layout:y="1738.5" /><layout:dimensions layout:height="35.0" layout:width="120.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa192" layout:id="sa192_glyph"><layout:boundingBox><layout:position layout:x="285.0" layout:y="874.5" /><layout:dimensions layout:height="35.0" layout:width="150.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa194" layout:id="sa194_glyph"><layout:boundingBox><layout:position layout:x="2180.0" layout:y="677.5" /><layout:dimensions layout:height="37.0" layout:width="80.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa195" layout:id="sa195_glyph"><layout:boundingBox><layout:position layout:x="2097.5" layout:y="1605.75" /><layout:dimensions layout:height="32.5" layout:width="85.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa197" layout:id="sa197_glyph"><layout:boundingBox><layout:position layout:x="1113.0" layout:y="2101.5" /><layout:dimensions layout:height="35.0" layout:width="150.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa201" layout:id="sa201_glyph"><layout:boundingBox><layout:position layout:x="1145.0" layout:y="427.5" /><layout:dimensions layout:height="25.0" layout:width="70.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa202" layout:id="sa202_glyph"><layout:boundingBox><layout:position layout:x="2061.0" layout:y="204.0" /><layout:dimensions layout:height="30.0" layout:width="90.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa203" layout:id="sa203_glyph"><layout:boundingBox><layout:position layout:x="2350.0" layout:y="436.0" /><layout:dimensions layout:height="30.0" layout:width="145.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa208" layout:id="sa208_glyph"><layout:boundingBox><layout:position layout:x="359.0" layout:y="1563.5" /><layout:dimensions layout:height="35.0" layout:width="130.0" /></layout:boundingBox></layout:generalGlyph><layout:generalGlyph layout:reference="sa209" layout:id="sa209_glyph"><layout:boundingBox><layout:position layout:x="359.0" layout:y="1612.5" /><layout:dimensions layout:height="35.0" layout:width="130.0" /></layout:boundingBox></layout:generalGlyph></layout:listOfAdditionalGraphicalObjects></layout:layout></layout:listOfLayouts><qual:listOfQualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="ACE2:AGTR1_complex" qual:constant="false" qual:id="csa4"><annotation><rdf:RDF>
artenobot's avatar
artenobot committed
3
4
5
6
7
8
<rdf:Description rdf:about="#s236">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:25225202" />
</rdf:Bag>
</bqbiol:isDescribedBy>
cylon-x's avatar
cylon-x committed
9
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:AGTR1_cytoplasm&amp;ACE2_cytoplasm&amp;!angiotensin II_simple_molecule_cytoplasm" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s236" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
10
11
12
13
14
15
16
17
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="ACE2-Spike complex_complex" qual:constant="false" qual:id="csa5"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s132">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:32275855" />
</rdf:Bag>
</bqbiol:isDescribedBy>
artenobot's avatar
artenobot committed
18
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:ACE2_cytoplasm&amp;S|S&amp;TMPRSS2&amp;!Camostat mesilate_drug" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s132" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
19
20
21
22
23
24
25
26
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="MAS1:AGTR1_complex" qual:constant="false" qual:id="csa9"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s146">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:15809376" />
</rdf:Bag>
</bqbiol:isDescribedBy>
cylon-x's avatar
cylon-x committed
27
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:AGTR1_cytoplasm_active&amp;MAS1_cytoplasm" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s146" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
28
29
30
31
32
33
34
35
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="angiotensin I_simple_molecule" qual:constant="false" qual:id="sa21"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s3">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.chebi:CHEBI%3A2718" />
</rdf:Bag>
</bqbiol:isEncodedBy>
artenobot's avatar
artenobot committed
36
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:AGT&amp;REN|angiotensin 1-12_simple_molecule&amp;ACE_cytoplasm|CTSD|CTSG&amp;AGT" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s3" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
37
38
39
40
41
42
43
44
45
46
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="angiotensin 1-9_simple_molecule" qual:constant="false" qual:id="sa22"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s10">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.chebi:CHEBI%3A80128" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:angiotensin I_simple_molecule&amp;ACE2_cytoplasm" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s10" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
artenobot's avatar
artenobot committed
47
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="angiotensin II_simple_molecule_cytoplasm" qual:constant="false" qual:id="sa23"><annotation><rdf:RDF>
artenobot's avatar
artenobot committed
48
49
50
<rdf:Description rdf:about="#s4">
<bqbiol:isEncodedBy>
<rdf:Bag>
artenobot's avatar
artenobot committed
51
<rdf:li rdf:resource="urn:miriam:obo.chebi:CHEBI%3A48432" />
artenobot's avatar
artenobot committed
52
53
</rdf:Bag>
</bqbiol:isEncodedBy>
artenobot's avatar
artenobot committed
54
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:angiotensin I_simple_molecule&amp;ACE_cytoplasm|S|angiotensin 1-12_simple_molecule&amp;CMA1|angiotensin I_simple_molecule&amp;CMA1|angiotensin I_simple_molecule&amp;KLK1" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s4" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
55
</rdf:RDF>
artenobot's avatar
artenobot committed
56
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="angiotensin 1-7_simple_molecule_cytoplasm" qual:constant="false" qual:id="sa24"><annotation><rdf:RDF>
artenobot's avatar
artenobot committed
57
58
59
60
61
62
<rdf:Description rdf:about="#s12">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.chebi:CHEBI%3A55438" />
</rdf:Bag>
</bqbiol:isEncodedBy>
cylon-x's avatar
cylon-x committed
63
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:ACE_cytoplasm_active|MME_cytoplasm&amp;angiotensin 1-9_simple_molecule|ACE2_cytoplasm|PRCP&amp;angiotensin II_simple_molecule_cytoplasm|angiotensin I_simple_molecule&amp;MME_cytoplasm|angiotensin 1-12_simple_molecule&amp;MME_cytoplasm|angiotensin I_simple_molecule&amp;THOP1|angiotensin I_simple_molecule&amp;PREP" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s12" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
64
</rdf:RDF>
cylon-x's avatar
cylon-x committed
65
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="AGTR2_cytoplasm_active" qual:constant="false" qual:id="sa25"><annotation><rdf:RDF>
artenobot's avatar
artenobot committed
66
67
68
69
70
71
<rdf:Description rdf:about="#s157">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A338" />
</rdf:Bag>
</bqbiol:isDescribedBy>
artenobot's avatar
artenobot committed
72
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:AGTR2_cytoplasm&amp;CGP42112A_drug|angiotensin II_simple_molecule_cytoplasm|angiotensin A_simple_molecule&amp;AGTR2_cytoplasm|AGTR2_cytoplasm&amp;angiotensin 1-7_simple_molecule_cytoplasm|AGTR2_cytoplasm&amp;angiotensin 1-9_simple_molecule" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s157" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
73
74
75
76
77
78
79
80
81
82
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="AGTR1_cytoplasm" qual:constant="true" qual:id="sa26"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s15">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A336" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:AGTR1_cytoplasm" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s15" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
cylon-x's avatar
cylon-x committed
83
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="MAS1_cytoplasm_active" qual:constant="false" qual:id="sa27"><annotation><rdf:RDF>
artenobot's avatar
artenobot committed
84
85
86
87
88
89
<rdf:Description rdf:about="#s82">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A6899" />
</rdf:Bag>
</bqbiol:isEncodedBy>
artenobot's avatar
artenobot committed
90
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:MAS1_cytoplasm&amp;angiotensin 1-5_simple_molecule|MAS1_cytoplasm&amp;AR234960_drug|MAS1_cytoplasm&amp;angiotensin 1-7_simple_molecule_cytoplasm" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s82" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
91
</rdf:RDF>
cylon-x's avatar
cylon-x committed
92
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="ACE_cytoplasm" qual:constant="false" qual:id="sa28"><annotation><rdf:RDF>
artenobot's avatar
artenobot committed
93
94
95
96
97
98
99
100
101
102
103
<rdf:Description rdf:about="#s6">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A2707" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A2707" />
</rdf:Bag>
</bqbiol:isEncodedBy>
cylon-x's avatar
cylon-x committed
104
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:estradiol_simple_molecule&amp;!Calcitriol_simple_molecule_cell" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s6" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
105
106
107
108
109
110
111
112
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="ACE2_cytoplasm" qual:constant="false" qual:id="sa30"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s9">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A13557" />
</rdf:Bag>
</bqbiol:isEncodedBy>
cylon-x's avatar
cylon-x committed
113
114
115
116
117
118
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A13557" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:estradiol_simple_molecule|Calcitriol_simple_molecule_cytoplasm&amp;ACE2_gene&amp;!S|!SARS-CoV-2 infection_phenotype|ACE2_gene&amp;aging_phenotype|ACE2_gene&amp;!hypertension_phenotype&amp;! Diabetes mellitus, type II_phenotype" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s9" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
119
120
121
122
123
124
125
126
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="angiotensin 1-5_simple_molecule" qual:constant="false" qual:id="sa32"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s7">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.chebi:CHEBI%3A80129" />
</rdf:Bag>
</bqbiol:isEncodedBy>
cylon-x's avatar
cylon-x committed
127
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:angiotensin 1-7_simple_molecule_cytoplasm&amp;ACE_cytoplasm_active" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s7" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
128
</rdf:RDF>
artenobot's avatar
artenobot committed
129
130
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="AGT" qual:constant="false" qual:id="sa34"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s1">
artenobot's avatar
artenobot committed
131
132
<bqbiol:isEncodedBy>
<rdf:Bag>
artenobot's avatar
artenobot committed
133
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A333" />
artenobot's avatar
artenobot committed
134
135
136
137
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
artenobot's avatar
artenobot committed
138
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A333" />
artenobot's avatar
artenobot committed
139
140
</rdf:Bag>
</bqbiol:isEncodedBy>
artenobot's avatar
artenobot committed
141
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:ethynylestradiol_simple_molecule" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s1" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
142
</rdf:RDF>
artenobot's avatar
artenobot committed
143
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="Calcitriol_simple_molecule_cell" qual:constant="true" qual:id="sa37"><annotation><rdf:RDF>
artenobot's avatar
artenobot committed
144
145
146
147
148
149
<rdf:Description rdf:about="#s13">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.chebi:CHEBI%3A17823" />
</rdf:Bag>
</bqbiol:isEncodedBy>
artenobot's avatar
artenobot committed
150
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:Calcitriol_simple_molecule_cell" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s13" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
151
</rdf:RDF>
artenobot's avatar
artenobot committed
152
153
154
155
156
157
158
159
160
161
162
163
164
165
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="S" qual:constant="true" qual:id="sa38"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s14">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:uniprot:P0DTC2" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:uniprot:P59594" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:S" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s14" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
artenobot's avatar
artenobot committed
166
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="MME_cytoplasm" qual:constant="true" qual:id="sa39"><annotation><rdf:RDF>
artenobot's avatar
artenobot committed
167
168
169
170
171
172
<rdf:Description rdf:about="#s18">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A7154" />
</rdf:Bag>
</bqbiol:isEncodedBy>
artenobot's avatar
artenobot committed
173
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:MME_cytoplasm" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s18" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="TMPRSS2" qual:constant="false" qual:id="sa40"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s176">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A11876" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A11876" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:androgen_simple_molecule" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s176" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="ADAM17" qual:constant="true" qual:id="sa43"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s29">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A195" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:ADAM17" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s29" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
cylon-x's avatar
cylon-x committed
198
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="sex, male_phenotype" qual:constant="true" qual:id="sa44"><annotation><rdf:RDF>
artenobot's avatar
artenobot committed
199
200
201
202
203
204
<rdf:Description rdf:about="#s30">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:mesh:D008297" />
</rdf:Bag>
</bqbiol:isDescribedBy>
cylon-x's avatar
cylon-x committed
205
206
207
208
209
210
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:mesh:D008297" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:sex, male_phenotype" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s30" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
211
212
213
214
215
216
217
218
219
220
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="Camostat mesilate_drug" qual:constant="true" qual:id="sa45"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s31">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.chebi:CHEBI%3A135632" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:Camostat mesilate_drug" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s31" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
artenobot's avatar
artenobot committed
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="PRCP" qual:constant="true" qual:id="sa47"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s33">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A9344" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:PRCP" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s33" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="THOP1" qual:constant="true" qual:id="sa48"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s34">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A11793" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:THOP1" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s34" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="alamandine_simple_molecule" qual:constant="false" qual:id="sa49"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s36">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubchem.compound:44192273" />
</rdf:Bag>
</bqbiol:isDescribedBy>
artenobot's avatar
artenobot committed
246
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:angiotensin 1-7_simple_molecule_cytoplasm|angiotensin A_simple_molecule&amp;ACE2_cytoplasm" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s36" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
247
</rdf:RDF>
cylon-x's avatar
cylon-x committed
248
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="MRGPRD_cytoplasm_active" qual:constant="false" qual:id="sa50"><annotation><rdf:RDF>
artenobot's avatar
artenobot committed
249
250
251
252
253
254
<rdf:Description rdf:about="#s107">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A29626" />
</rdf:Bag>
</bqbiol:isEncodedBy>
artenobot's avatar
artenobot committed
255
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:MRGPRD_cytoplasm&amp;alamandine_simple_molecule|MRGPRD_cytoplasm&amp;angiotensin 1-7_simple_molecule_cytoplasm" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s107" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
256
257
258
259
260
261
262
263
264
265
266
267
268
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="angiotensin A_simple_molecule" qual:constant="false" qual:id="sa51"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s38">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:kegg.compound:C20970" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubchem.compound:91691124" />
</rdf:Bag>
</bqbiol:isEncodedBy>
artenobot's avatar
artenobot committed
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:angiotensin II_simple_molecule_cytoplasm" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s38" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="aging_phenotype" qual:constant="true" qual:id="sa54"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s41">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.go:GO%3A0007568" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:aging_phenotype" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s41" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="vasoconstriction_phenotype" qual:constant="false" qual:id="sa56"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s226">
<bqmodel:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:mesh:D014661" />
</rdf:Bag>
</bqmodel:isDescribedBy>
cylon-x's avatar
cylon-x committed
287
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:AGTR2_cytoplasm_active|MAS1_cytoplasm_active|LNPEP_cytoplasm_active|MRGPRD_cytoplasm_active|AGTR1_cytoplasm_active" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s226" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
288
289
290
291
292
293
294
295
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="inflammatory response_phenotype" qual:constant="false" qual:id="sa61"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s32">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.go:GO%3A0006954" />
</rdf:Bag>
</bqbiol:isDescribedBy>
cylon-x's avatar
cylon-x committed
296
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:MRGPRD_cytoplasm_active|MAS1_cytoplasm_active|LNPEP_cytoplasm_active|AGTR1_cytoplasm_active" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s32" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
297
298
299
300
301
302
303
304
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="angiotensin III_simple_molecule" qual:constant="false" qual:id="sa62"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s54">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.chebi:CHEBI%3A89666" />
</rdf:Bag>
</bqbiol:isDescribedBy>
cylon-x's avatar
cylon-x committed
305
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:angiotensin II_simple_molecule_cytoplasm&amp;ENPEP_cytoplasm_active" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s54" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
306
307
308
309
310
311
312
313
314
315
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="angiotensin IV_simple_molecule" qual:constant="false" qual:id="sa63"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s55">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.chebi:CHEBI%3A80127" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:angiotensin III_simple_molecule&amp;ANPEP " /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s55" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
cylon-x's avatar
cylon-x committed
316
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="ENPEP_cytoplasm_active" qual:constant="false" qual:id="sa64"><annotation><rdf:RDF>
artenobot's avatar
artenobot committed
317
318
319
320
321
322
<rdf:Description rdf:about="#s232">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A3355" />
</rdf:Bag>
</bqbiol:isEncodedBy>
cylon-x's avatar
cylon-x committed
323
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:ENPEP_cytoplasm&amp;!QGC001_drug|ENPEP_cytoplasm&amp;!sex, male_phenotype" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s232" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
324
325
326
327
328
329
330
331
332
333
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="ANPEP " qual:constant="true" qual:id="sa65"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s57">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A500" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:ANPEP " /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s57" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
artenobot's avatar
artenobot committed
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="Lisinopril_drug" qual:constant="true" qual:id="sa66"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s23">
<bqbiol:is>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.chebi:CHEBI%3A43755" />
</rdf:Bag>
</bqbiol:is>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:Lisinopril_drug" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s23" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="Losartan_drug" qual:constant="true" qual:id="sa69"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s110">
<bqbiol:is>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.chebi:CHEBI%3A6541" />
</rdf:Bag>
</bqbiol:is>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:Losartan_drug" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s110" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="CGP42112A_drug" qual:constant="true" qual:id="sa70"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s22">
<bqbiol:is>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.chebi:CHEBI%3A147302" />
</rdf:Bag>
</bqbiol:is>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:CGP42112A_drug" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s22" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="REN" qual:constant="false" qual:id="sa71"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s61">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A9958" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A9958" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A9958" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:!Calcitriol_simple_molecule_cell" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s61" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="ACE2, soluble" qual:constant="false" qual:id="sa73"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s64">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc.symbol:ACE2" />
</rdf:Bag>
</bqbiol:isEncodedBy>
cylon-x's avatar
cylon-x committed
387
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:ADAM17|AGTR1_cytoplasm_active&amp;ACE2_cytoplasm" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s64" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
388
</rdf:RDF>
artenobot's avatar
artenobot committed
389
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="MAS1_cytoplasm" qual:constant="false" qual:id="sa77"><annotation><rdf:RDF>
artenobot's avatar
artenobot committed
390
391
392
393
394
395
<rdf:Description rdf:about="#s103">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A6899" />
</rdf:Bag>
</bqbiol:isEncodedBy>
cylon-x's avatar
cylon-x committed
396
397
398
399
400
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A6899" />
</rdf:Bag>
</bqbiol:isEncodedBy>
artenobot's avatar
artenobot committed
401
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:!aldosterone_simple_molecule" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s103" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="AGTR2_cytoplasm" qual:constant="true" qual:id="sa79"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s156">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A338" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:AGTR2_cytoplasm" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s156" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="MRGPRD_cytoplasm" qual:constant="true" qual:id="sa94"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s188">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A29626" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:MRGPRD_cytoplasm" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s188" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
artenobot's avatar
artenobot committed
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="angiotensin II_simple_molecule_default_compartment" qual:constant="false" qual:id="sa95"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s97">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.chebi:CHEBI%3A48432" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:SARS-CoV-2 infection_phenotype" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s97" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="angiotensin 1-7_simple_molecule_default_compartment" qual:constant="false" qual:id="sa96"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s190">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.chebi:CHEBI%3A55438" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:angiotensin II_simple_molecule_default_compartment&amp;ACE2, soluble" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s190" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
cylon-x's avatar
cylon-x committed
439
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="ACE2_cytoplasm_active" qual:constant="false" qual:id="sa98"><annotation><rdf:RDF>
artenobot's avatar
artenobot committed
440
441
442
443
444
445
<rdf:Description rdf:about="#s114">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A13557" />
</rdf:Bag>
</bqbiol:isEncodedBy>
cylon-x's avatar
cylon-x committed
446
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:ACE2_cytoplasm&amp;sex, male_phenotype|aging_phenotype|hypertension_phenotype&amp;ACE2_cytoplasm" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s114" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
447
</rdf:RDF>
cylon-x's avatar
cylon-x committed
448
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="ACE_cytoplasm_active" qual:constant="false" qual:id="sa100"><annotation><rdf:RDF>
artenobot's avatar
artenobot committed
449
450
451
452
453
454
<rdf:Description rdf:about="#s117">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A2707" />
</rdf:Bag>
</bqbiol:isEncodedBy>
cylon-x's avatar
cylon-x committed
455
456
457
458
459
460
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A2707" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:ACE_cytoplasm&amp;!aging_phenotype&amp;!sex, male_phenotype|ACE_cytoplasm&amp;aldosterone_simple_molecule|ACE_cytoplasm&amp;hypertension_phenotype|ACE_cytoplasm&amp;!Lisinopril_drug|ACE_cytoplasm&amp;ABO blood group system_phenotype" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s117" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
461
</rdf:RDF>
cylon-x's avatar
cylon-x committed
462
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="AGTR1_cytoplasm_active" qual:constant="false" qual:id="sa102"><annotation><rdf:RDF>
artenobot's avatar
artenobot committed
463
464
465
466
467
468
469
470
471
472
473
<rdf:Description rdf:about="#s120">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A336" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A336" />
</rdf:Bag>
</bqbiol:isEncodedBy>
cylon-x's avatar
cylon-x committed
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A336" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A336" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A336" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A336" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A336" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A336" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A336" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:angiotensin II_simple_molecule_cytoplasm|angiotensin IV_simple_molecule|angiotensin A_simple_molecule&amp;AGTR1_cytoplasm|AGTR1_cytoplasm&amp;!Losartan_drug|AGTR1_cytoplasm&amp;!angiotensin 1-7_simple_molecule_cytoplasm|angiotensin II_simple_molecule_cytoplasm&amp;!MAS1:AGTR1_complex" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s120" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="PREP" qual:constant="true" qual:id="sa120"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s143">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A9358" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:PREP" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s143" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="angiotensin 1-12_simple_molecule" qual:constant="true" qual:id="sa121"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s144">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:27465904" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:angiotensin 1-12_simple_molecule" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s144" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="CMA1" qual:constant="true" qual:id="sa122"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s145">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A2097" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:CMA1" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s145" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="androgen_simple_molecule" qual:constant="true" qual:id="sa132"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s177">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.chebi:CHEBI%3A50113" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:androgen_simple_molecule" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s177" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
artenobot's avatar
artenobot committed
547
548
549
550
551
552
553
554
555
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="ethynylestradiol_simple_molecule" qual:constant="true" qual:id="sa134"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s179">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.chebi:CHEBI%3A4903" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:ethynylestradiol_simple_molecule" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s179" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
artenobot's avatar
artenobot committed
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="CTSD" qual:constant="true" qual:id="sa136"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s181">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A2529" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:CTSD" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s181" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="CTSG" qual:constant="true" qual:id="sa137"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s191">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A2532" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:CTSG" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s191" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="angiotensin 1-4_simple_molecule" qual:constant="false" qual:id="sa138"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s192">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:22490446" />
</rdf:Bag>
</bqbiol:isDescribedBy>
artenobot's avatar
artenobot committed
581
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:angiotensin 1-12_simple_molecule&amp;MME_cytoplasm" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s192" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="KLK1" qual:constant="true" qual:id="sa144"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s208">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A6357" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:KLK1" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s208" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="LNPEP_cytoplasm" qual:constant="true" qual:id="sa152"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s217">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A6656" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:LNPEP_cytoplasm" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s217" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
cylon-x's avatar
cylon-x committed
601
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="LNPEP_cytoplasm_active" qual:constant="false" qual:id="sa156"><annotation><rdf:RDF>
artenobot's avatar
artenobot committed
602
603
604
605
606
607
608
609
<rdf:Description rdf:about="#s224">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A6656" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:LNPEP_cytoplasm&amp;angiotensin IV_simple_molecule|LNPEP_cytoplasm&amp;angiotensin 3-7_simple_molecule" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s224" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
artenobot's avatar
artenobot committed
610
611
612
613
614
615
616
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="oxidative stress_phenotype" qual:constant="false" qual:id="sa157"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s225">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.go:GO%3A0006979" />
</rdf:Bag>
</bqbiol:isDescribedBy>
cylon-x's avatar
cylon-x committed
617
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:MAS1_cytoplasm_active|AGTR1_cytoplasm_active" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s225" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
618
619
620
621
622
623
624
625
626
627
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="AR234960_drug" qual:constant="true" qual:id="sa159"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s227">
<bqbiol:is>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubchem.compound:146025955" />
</rdf:Bag>
</bqbiol:is>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:AR234960_drug" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s227" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
artenobot's avatar
artenobot committed
628
629
630
631
632
633
634
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="angiotensin 3-7_simple_molecule" qual:constant="false" qual:id="sa160"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s228">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:30934934" />
</rdf:Bag>
</bqbiol:isDescribedBy>
artenobot's avatar
artenobot committed
635
636
637
638
639
640
641
642
643
644
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:angiotensin 1-7_simple_molecule_cytoplasm|angiotensin II_simple_molecule_cytoplasm|angiotensin IV_simple_molecule" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s228" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="QGC001_drug" qual:constant="true" qual:id="sa161"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s230">
<bqmodel:is>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:24337978" />
</rdf:Bag>
</bqmodel:is>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:QGC001_drug" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s230" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
645
</rdf:RDF>
artenobot's avatar
artenobot committed
646
647
648
649
650
651
652
653
654
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="ENPEP_cytoplasm" qual:constant="true" qual:id="sa162"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s56">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A3355" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:ENPEP_cytoplasm" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s56" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
artenobot's avatar
artenobot committed
655
656
657
658
659
660
661
662
663
664
665
666
667
668
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="SARS-CoV-2 infection_phenotype" qual:constant="true" qual:id="sa165"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s42">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:2697049" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:mesh:C000657245" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:SARS-CoV-2 infection_phenotype" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s42" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
artenobot's avatar
artenobot committed
669
670
671
672
673
674
675
676
677
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="viral replication cycle_phenotype" qual:constant="false" qual:id="sa166"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s237">
<bqmodel:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:mesh:D014661" />
</rdf:Bag>
</bqmodel:isDescribedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:ACE2-Spike complex_complex" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s237" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
artenobot's avatar
artenobot committed
678
679
680
681
682
683
684
685
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="ACE2_gene" qual:constant="true" qual:id="sa168"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s238">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:hgnc:HGNC%3A13557" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:ACE2_gene" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s238" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
686
</rdf:RDF>
cylon-x's avatar
cylon-x committed
687
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="estradiol_simple_molecule" qual:constant="true" qual:id="sa169"><annotation><rdf:RDF>
artenobot's avatar
artenobot committed
688
689
690
691
692
693
<rdf:Description rdf:about="#s239">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.chebi:CHEBI%3A16469" />
</rdf:Bag>
</bqbiol:isEncodedBy>
cylon-x's avatar
cylon-x committed
694
695
696
697
698
699
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.chebi:CHEBI%3A16469" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:estradiol_simple_molecule" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s239" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
700
</rdf:RDF>
artenobot's avatar
artenobot committed
701
702
703
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="fibrosis_phenotype" qual:constant="false" qual:id="sa171"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s241">
<bqbiol:isDescribedBy>
artenobot's avatar
artenobot committed
704
<rdf:Bag>
artenobot's avatar
artenobot committed
705
<rdf:li rdf:resource="urn:miriam:mesh:D005355" />
artenobot's avatar
artenobot committed
706
</rdf:Bag>
artenobot's avatar
artenobot committed
707
</bqbiol:isDescribedBy>
cylon-x's avatar
cylon-x committed
708
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:MAS1_cytoplasm_active|AGTR2_cytoplasm_active|AGTR1_cytoplasm_active" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s241" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
709
</rdf:RDF>
artenobot's avatar
artenobot committed
710
711
712
713
714
715
716
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="thrombosis_phenotype" qual:constant="false" qual:id="sa172"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s242">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:mesh:D013927" />
</rdf:Bag>
</bqbiol:isDescribedBy>
cylon-x's avatar
cylon-x committed
717
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:MAS1_cytoplasm_active|AGTR1_cytoplasm_active" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s242" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
718
719
720
721
722
723
724
725
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="neurodegeneration_phenotype" qual:constant="false" qual:id="sa190"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s259">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:mesh:D009410" />
</rdf:Bag>
</bqbiol:isDescribedBy>
cylon-x's avatar
cylon-x committed
726
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:LNPEP_cytoplasm_active" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s259" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
727
728
729
730
731
732
733
734
735
736
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="ABO blood group system_phenotype" qual:constant="true" qual:id="sa192"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s260">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:mesh:D000017" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:ABO blood group system_phenotype" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s260" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
cylon-x's avatar
cylon-x committed
737
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="MME_cytoplasm_active" qual:constant="false" qual:id="sa194"><annotation><rdf:RDF><rdf:Description rdf:about="#s264"><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:MME_cytoplasm&amp;sex, male_phenotype" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s264" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description></rdf:RDF></annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="aldosterone_simple_molecule" qual:constant="false" qual:id="sa195"><annotation><rdf:RDF>
artenobot's avatar
artenobot committed
738
739
740
741
742
743
<rdf:Description rdf:about="#s265">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.chebi:CHEBI%3A27584" />
</rdf:Bag>
</bqbiol:isEncodedBy>
cylon-x's avatar
cylon-x committed
744
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:AGTR1_cytoplasm_active" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s265" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
745
</rdf:RDF>
artenobot's avatar
artenobot committed
746
747
748
749
750
751
752
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="cognition_phenotype" qual:constant="false" qual:id="sa197"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s267">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:mesh:D003071" />
</rdf:Bag>
</bqbiol:isEncodedBy>
cylon-x's avatar
cylon-x committed
753
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:AGTR1_cytoplasm_active|LNPEP_cytoplasm_active" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s267" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
754
755
756
757
758
759
760
761
762
763
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="Calcitriol_simple_molecule_cytoplasm" qual:constant="true" qual:id="sa201"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s270">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.chebi:CHEBI%3A17823" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:Calcitriol_simple_molecule_cytoplasm" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s270" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
artenobot's avatar
artenobot committed
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="hypertension_phenotype" qual:constant="true" qual:id="sa202"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s271">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:mesh:D006973" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:hypertension_phenotype" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s271" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name=" Diabetes mellitus, type II_phenotype" qual:constant="true" qual:id="sa203"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s272">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:mesh:D003924" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function: Diabetes mellitus, type II_phenotype" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s272" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="pulmonary edema_phenotype" qual:constant="false" qual:id="sa208"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s240">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:mesh:D011654" />
</rdf:Bag>
</bqbiol:isDescribedBy>
cylon-x's avatar
cylon-x committed
789
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:AGTR1_cytoplasm_active" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s240" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
790
791
792
793
794
795
796
797
</rdf:RDF>
</annotation></qual:qualitativeSpecies><qual:qualitativeSpecies qual:maxLevel="1" qual:compartment="comp1" qual:name="platelet aggregation_phenotype" qual:constant="false" qual:id="sa209"><annotation><rdf:RDF>
<rdf:Description rdf:about="#s276">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:obo.go:GO%3A0070527" />
</rdf:Bag>
</bqbiol:isEncodedBy>
cylon-x's avatar
cylon-x committed
798
<bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:function:AGTR1_cytoplasm_active" /></rdf:Bag></bqbiol:isDescribedBy><bqbiol:isDescribedBy><rdf:Bag><rdf:li rdf:resource="urn:casq:cdid:s276" /></rdf:Bag></bqbiol:isDescribedBy></rdf:Description>
artenobot's avatar
artenobot committed
799
</rdf:RDF>
cylon-x's avatar
cylon-x committed
800
</annotation></qual:qualitativeSpecies></qual:listOfQualitativeSpecies><qual:listOfTransitions><qual:transition qual:id="tr_csa4"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa26" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_csa4_in_0" /><qual:input qual:qualitativeSpecies="sa30" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_csa4_in_1" /><qual:input qual:qualitativeSpecies="sa23" qual:transitionEffect="none" qual:sign="negative" qual:id="tr_csa4_in_2" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="csa4" qual:transitionEffect="assignmentLevel" qual:id="tr_csa4_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><and /><apply><eq /><ci>sa26</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa30</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa23</ci><cn type="integer">0</cn></apply></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>Because AT1R seems to be essential for Ang-II–mediated ACE2 internalization, we also tested whether ACE2 and AT1R physically interact. Coimmunoprecipitation experiments confirmed this dimerization in control conditions (Figure 5B, second lane). However, Ang-II treatment decreased this interaction in a time-dependent manner [...]. PMID:25225202
artenobot's avatar
artenobot committed
801
802
803
804
805
806
807
808
809
810
811
812
813
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re98">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:25225202" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
artenobot's avatar
artenobot committed
814
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_csa5"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa30" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_csa5_in_0" /><qual:input qual:qualitativeSpecies="sa38" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_csa5_in_1" /><qual:input qual:qualitativeSpecies="sa45" qual:transitionEffect="none" qual:sign="negative" qual:id="tr_csa5_in_2" /><qual:input qual:qualitativeSpecies="sa40" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_csa5_in_3" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="csa5" qual:transitionEffect="assignmentLevel" qual:id="tr_csa5_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><or /><apply><and /><apply><eq /><ci>sa30</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa38</ci><cn type="integer">1</cn></apply></apply><apply><and /><apply><eq /><ci>sa38</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa40</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa45</ci><cn type="integer">0</cn></apply></apply></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>Recently, ACE2 was reported as an entry receptor for SARS-CoV-2. In this study, we present the crystal structure of the C-terminal domain of SARS-CoV-2 (SARS-CoV-2-CTD) spike (S) protein in complex with human ACE2 (hACE2), which reveals a hACE2-binding mode similar overall to that observed for SARS-CoV. PMID:32275855
artenobot's avatar
artenobot committed
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
</p>
<p>SARS-CoV-2 can use TMPRSS2 for S protein priming and camostat mesylate, an inhibitor of TMPRSS2, blocks SARS-CoV-2 infection of lung cells. PMID:32142651
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re102">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:32275855" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:uniprot:P0DTC2" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re150">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:32142651" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:uniprot:P0DTC2" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
cylon-x's avatar
cylon-x committed
852
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_csa9"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa102" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_csa9_in_0" /><qual:input qual:qualitativeSpecies="sa77" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_csa9_in_1" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="csa9" qual:transitionEffect="assignmentLevel" qual:id="tr_csa9_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><and /><apply><eq /><ci>sa102</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa77</ci><cn type="integer">1</cn></apply></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>The G-protein-coupled receptor Mas, encoded by the Mas proto-oncogene, has been identified as an endogenous receptor for the heptapeptide angiotensin-(1-7); however, the receptor is also suggested to be involved in actions of angiotensin II. The study tested whether this could be mediated indirectly through an interaction with the angiotensin II type 1 receptor, AT1. In transfected mammalian cells, Mas was not activated by angiotensin II; however, AT1 receptor-mediated, angiotensin II-induced production of inositol phosphates and mobilization of intracellular Ca2+ was diminished by 50% after coexpression of Mas, despite a concomitant increase in angiotensin II binding capacity. Mas and the AT1 receptor formed a constitutive hetero-oligomeric complex that was unaffected by the presence of agonists or antagonists of the 2 receptors. In vivo, Mas acts as an antagonist of the AT1 receptor; mice lacking the Mas gene show enhanced angiotensin II-mediated vasoconstriction in mesenteric microvessels. These results demonstrate that Mas can hetero-oligomerize with the AT1 receptor and by so doing inhibit the actions of angiotensin II. PMID:15809376
artenobot's avatar
artenobot committed
853
854
855
856
857
858
859
860
861
862
863
864
865
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re115">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:15809376" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:40674" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
cylon-x's avatar
cylon-x committed
866
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa21"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa34" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa21_in_0" /><qual:input qual:qualitativeSpecies="sa71" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa21_in_1" /><qual:input qual:qualitativeSpecies="sa121" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa21_in_2" /><qual:input qual:qualitativeSpecies="sa28" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa21_in_3" /><qual:input qual:qualitativeSpecies="sa136" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa21_in_4" /><qual:input qual:qualitativeSpecies="sa137" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa21_in_5" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa21" qual:transitionEffect="assignmentLevel" qual:id="tr_sa21_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><or /><apply><and /><apply><eq /><ci>sa34</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa71</ci><cn type="integer">1</cn></apply></apply><apply><and /><apply><eq /><ci>sa121</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa28</ci><cn type="integer">1</cn></apply></apply><apply><and /><apply><or /><apply><eq /><ci>sa136</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa137</ci><cn type="integer">1</cn></apply></apply><apply><eq /><ci>sa34</ci><cn type="integer">1</cn></apply></apply></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>Role_of_spike_ACE2_interaction_in_pulmonary_blood_pressure_regulation_v3.xml)
artenobot's avatar
artenobot committed
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
Renin provides only one known function, to cleave the 10-amino acid precursor peptide angiotensin I (Ang-I),1 from the N terminus of mature angiotensinogen (AGT). PMID:10585461
</p>
<p>The study characterized Ang-(1-12) metabolism in the serum and kidney of the mRen2.Lewis rat, a model of high circulating renin and ACE expression. Ang-(1-12) processing to serum did not reveal the participation of renin; however, serum ACE readily converted Ang-(1-12) to Ang I with subsequent metabolism to Ang II. Ang I and Ang II forming activities for serum ACE were 102 and 104 fmol/ml/min serum (n=3), respectively, and both products were abolished by the potent ACE inhibitor lisinopril. PMID:22490446
</p>
<p>Apart from Renin, several enzymes were found to cleave angiotensinogen into Ang-I, such as cathepsin D (CTSD), cathepsin G (CTSG), and tonins. PMID:30934934
A human neutrophil protease, initially termed neutral peptide-generating protease, has been shown to cleave angiotensin II directly from angiotensinogen and has been identified as leukocyte cathepsin G. When purified neutrophils were disrupted by nitrogen cavitation and fractionated by differential centrifugation, 44 and 24% of the angiotensin II-generating activity was in the lysosomal and undisrupted cell fractions, respectively. The angiotensin II-generating protease of human neutrophils has been identified as cathepsin G on the basis of subcellular localization, substrate specificity, physicochemical characteristics, and antigenic identity. PMID:6172448
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re14">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:10585461" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re119">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:22490446" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10116" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re129">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:6172448" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa22"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa21" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa22_in_0" /><qual:input qual:qualitativeSpecies="sa30" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa22_in_1" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa22" qual:transitionEffect="assignmentLevel" qual:id="tr_sa22_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><and /><apply><eq /><ci>sa21</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa30</ci><cn type="integer">1</cn></apply></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>Recombinant ACE2 hydrolyzes the carboxy terminal leucine from angiotensin I to generate angiotensin 1-9, which is converted to smaller angiotensin peptides by ACE in vitro and by cardiomyocytes in culture. PMID:10969042
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re9">
<bqmodel:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:10969042" />
</rdf:Bag>
</bqmodel:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
cylon-x's avatar
cylon-x committed
924
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa23"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa21" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa23_in_0" /><qual:input qual:qualitativeSpecies="sa28" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa23_in_1" /><qual:input qual:qualitativeSpecies="sa38" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa23_in_2" /><qual:input qual:qualitativeSpecies="sa121" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa23_in_3" /><qual:input qual:qualitativeSpecies="sa122" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa23_in_4" /><qual:input qual:qualitativeSpecies="sa144" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa23_in_5" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa23" qual:transitionEffect="assignmentLevel" qual:id="tr_sa23_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><or /><apply><and /><apply><eq /><ci>sa21</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa28</ci><cn type="integer">1</cn></apply></apply><apply><eq /><ci>sa38</ci><cn type="integer">1</cn></apply><apply><and /><apply><eq /><ci>sa121</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa122</ci><cn type="integer">1</cn></apply></apply><apply><and /><apply><eq /><ci>sa21</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa122</ci><cn type="integer">1</cn></apply></apply><apply><and /><apply><eq /><ci>sa21</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa144</ci><cn type="integer">1</cn></apply></apply></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>ACE2 and ACE catalytic activity has been analyzed in CHO cells expressing human ACE2. ACE converted the decapeptide Ang I to Ang II. ACE2, in contrast, converted Ang I to the nonapeptide Ang1-9. PMID:10969042
artenobot's avatar
artenobot committed
925
926
</p>
<p>ACE2 functions as a carboxypeptidase, cleaving a single residue from angiotensin I (AngI), generating Ang1-9, and a single  residue from angiotensin II (AngII) to generate Ang1-7. The ACE2 homologue ACE, by contrast, cleaves the decapeptide AngI into the  octapeptide AngII. Thus, ACE2 counterbalances the function of ACE and negatively regulates AngII production. To test whether Spike-Fc injections indeed affect the function of the renin-angiotensin system, AngII levels in the lungs of acid- and Spike-Fc–treated mice were analyzed. Acid aspiration increased AngII levels in the lungs of wild-type mice. Notably, the authors observed a further, significant increase in AngII levels in the lung tissue of mice treated with Spike-Fc. PMID:16007097
artenobot's avatar
artenobot committed
927
Adipocytes express all components of the renin-angiotensin system, and the renin-angiotensin system is involved in obesity and insulin resistance. The aim of this study was to investigate plasma Ang II in obese patients with type 2 diabetes mellitus (T2D) and the change during weight loss. Fifty Japanese obese subjects with T2D were enrolled. After 24 weeks of weight reduction diet, the mean body weight, visceral fat area (VFA), and hemoglobin A(1c) decreased significantly by 2.3%, 7.0%, and 8.3%, respectively. The mean plasma Ang II decreased by 24% and correlated with body weight both at baseline. PMID:19375596
artenobot's avatar
artenobot committed
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
961
962
963
</p>
<p>Overall the findings suggest that Ang-(1-12), not Ang I, is the better substrate for Ang II formation by chymase in adult rats. In addition, this confirms the previous observation that chymase (rather than ACE) is the main hydrolyzing enzyme responsible for Ang II generation from Ang-(1-12) in the adult rat heart. PMID:27465904
Since angiotensin-(1-12) [Ang-(1-12)] is a non-renin dependent alternate precursor for the generation of cardiac Ang peptides in rat tissue, the authors investigated the metabolism of Ang-(1-12) by plasma membranes (PM) isolated from human atrial appendage tissue from nine patients undergoing cardiac surgery for primary control of atrial fibrillation. PM was incubated with highly purified Ang-(1-12) for 1 h with or without renin-angiotensin system (RAS) inhibitors [lisinopril for angiotensin converting enzyme (ACE), SCH39370 for neprilysin (NEP), MLN-4760 for ACE2 and chymostatin for chymase].  In the absence of all RAS inhibitor, Ang-(1-12) was converted into Ang I (2%), Ang II (69%), Ang-(1-7) (5%), and Ang-(1-4) (2%). In the absence of all RAS inhibitor, only 22% of Ang-(1-12) was unmetabolized, whereas, in the presence of the all RAS inhibitors, 98% of Ang-(1-12) remained intact. The relative contribution of selective inhibition of ACE and chymase enzyme showed that Ang-(1-12) was primarily converted into Ang II (65%) by chymase while its hydrolysis into Ang II by ACE was significantly lower or undetectable. PMID:22180785
</p>
<p>Although angiotensin II (Ang II)-forming enzymatic activity in the human left cardiac ventricle is minimally inhibited by angiotensin I (Ang I) converting enzyme inhibitors, over 75% of this activity is inhibited by serine proteinase inhibitors. The authors report the identification and characterization of the major Ang II-forming, neutral serine proteinase, from left ventricular tissues of the human heart. A 115,150-fold purification from human cardiac membranes yielded a purified protein with an Mr of 30,000 by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Based upon its amino-terminal sequence, the major human cardiac Ang II-forming proteinase appears to be a novel member of the chymase subfamily of chymotrypsin-like serine proteinases. Human heart chymase was completely inhibited by the serine proteinase inhibitors, soybean trypsin inhibitor, phenylmethylsulfonyl fluoride, and chymostatin. It was partially inhibited by p-tosyl-L-phenylalanine chloromethyl ketone, but was not inhibited by p-tosyl-L-lysine chloromethyl ketone, and aprotinin. Also, human heart chymase was not inhibited by inhibitors of the other three classes of proteinases. Human heart chymase has a high specificity for the conversion of Ang I to Ang II and the Ang I-carboxyl-terminal dipeptide His-Leu. Human heart chymase did not degrade several peptide hormones, including Ang II, bradykinin, and vasoactive intestinal peptide, nor did it form Ang II from angiotensinogen. The high substrate specificity of human heart chymase for Ang I distinguishes it from other Ang II-forming enzymes including Ang I converting enzyme, tonin, kallikrein, cathepsin G, and other known chymases. PMID:2266130
</p>
<p>This study was undertaken to confirm a previous preliminary observation that hog pancreas kallikrein (EC 3.4.21.35) directly liberated an angiotensin-like substance from human plasma protein Cohn fraction IV-4 at an acidic pH of 4.0-5.0. The amino acid composition of the isolated pressor substance (residues/mol) was: Asp, 1.03; Val, 1.03; Ile, 1.00; Tyr, 0.69; Phe, 1.04; His, 0.91; Arg, 0.86; Pro, 0.86. This composition was identical with that of angiotensin. Since the reaction mixture was not contaminated with common proteolytic enzymes, such as trypsin, chymotrypsin, renin, cathepsin D and proangiotensin-converting enzyme, and other enzymes activated by kallikrein, it is clear that hog kallikrein directly produces angiotensin in vitro. PMID:6555043
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re3">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:10969042" />
</rdf:Bag>
</bqbiol:isDescribedBy>
</rdf:Description>
<rdf:Description rdf:about="#re94">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:16007097" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10090" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:uniprot:P59594" />
</rdf:Bag>
</bqbiol:isEncodedBy>
artenobot's avatar
artenobot committed
964
965
966
967
968
969
970
971
972
973
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:19375596" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
artenobot's avatar
artenobot committed
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
1001
1002
1003
1004
1005
1006
1007
1008
1009
1010
1011
1012
1013
1014
1015
1016
1017
1018
1019
1020
1021
1022
1023
1024
1025
1026
1027
1028
1029
1030
1031
1032
1033
1034
1035
1036
1037
1038
1039
1040
1041
1042
1043
1044
1045
1046
1047
1048
1049
1050
1051
1052
1053
1054
1055
1056
1057
1058
1059
1060
1061
1062
1063
1064
1065
1066
1067
1068
1069
1070
1071
1072
1073
1074
1075
1076
1077
1078
1079
1080
1081
1082
1083
1084
1085
1086
1087
1088
1089
1090
1091
1092
1093
1094
1095
1096
</rdf:Description>
<rdf:Description rdf:about="#re109">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:22180785" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re131">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:2266130" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re132">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9823" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:6555043" />
</rdf:Bag>
</bqbiol:isDescribedBy>
</rdf:Description>
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa24"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa22" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa24_in_0" /><qual:input qual:qualitativeSpecies="sa100" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa24_in_1" /><qual:input qual:qualitativeSpecies="sa39" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa24_in_2" /><qual:input qual:qualitativeSpecies="sa23" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa24_in_3" /><qual:input qual:qualitativeSpecies="sa30" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa24_in_4" /><qual:input qual:qualitativeSpecies="sa47" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa24_in_5" /><qual:input qual:qualitativeSpecies="sa21" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa24_in_6" /><qual:input qual:qualitativeSpecies="sa121" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa24_in_7" /><qual:input qual:qualitativeSpecies="sa48" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa24_in_8" /><qual:input qual:qualitativeSpecies="sa120" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa24_in_9" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa24" qual:transitionEffect="assignmentLevel" qual:id="tr_sa24_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><or /><apply><and /><apply><or /><apply><eq /><ci>sa100</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa39</ci><cn type="integer">1</cn></apply></apply><apply><eq /><ci>sa22</ci><cn type="integer">1</cn></apply></apply><apply><and /><apply><or /><apply><eq /><ci>sa30</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa47</ci><cn type="integer">1</cn></apply></apply><apply><eq /><ci>sa23</ci><cn type="integer">1</cn></apply></apply><apply><and /><apply><eq /><ci>sa21</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa39</ci><cn type="integer">1</cn></apply></apply><apply><and /><apply><eq /><ci>sa121</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa39</ci><cn type="integer">1</cn></apply></apply><apply><and /><apply><eq /><ci>sa21</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa48</ci><cn type="integer">1</cn></apply></apply><apply><and /><apply><eq /><ci>sa21</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa120</ci><cn type="integer">1</cn></apply></apply></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>Ang (1–7) can be generated by the action of ACE2 on Ang II or by the metabolism of Ang (1–9) by ACE and NEP (MME) in CHO cells transfected with human ACE and MME. Ang (1–9) was a better substrate for NEP than ACE. PMID:15283675
</p>
<p>The main role of ACE2 is the degradation of Ang II resulting in the formation of angiotensin 1-7 (Ang 1-7) which opposes the actions of Ang II. PMID:22536270
ACE2 metabolizes ANG II to Ang 1-7 in the kidney at neutral and basic pH, while prolylcarboxypeptidase catalyzes the same reaction at acidic pH. PMID:23392115
</p>
<p>Ang I can be cleaved by NEP (MME) to Ang (1–7) in CHO cells transfected with human MME. ACE and NEP hydrolysed Ang I efficiently, whereas ACE2 hydrolysed Ang I only very slowly. PMID:15283675
Angiotensin peptides are metabolized by several subsequent enzymatic steps: First, renin cleaves angiotensinogen, into angiotensin I (Ang I). Ang I can be metabolized by angiotensin-converting enzyme (ACE) resulting in the production of the bioactive octapeptide angiotensin II (Ang II), which interacts with AT1 and AT2 receptors. Alternatively, it can be processed first by ACE2 to the inactive peptide Ang-(1–9) and then by ACE to Ang-(1–7) or by neutral endopeptidase 24.11 (NEP) or prolylendopeptidase (PREP) directly to Ang-(1–7). Ang-(1–7) can also be generated by ACE2 from Ang II and interacts with its receptor Mas. PMID:23463883.
</p>
<p>The metabolism of Ang-(1-12) in renal cortical membranes also revealed the formation of Ang I; however, the main products were Ang-(1-7) and Ang-(1-4) at 129 and 310 fmol/mg/min protein (n=4), respectively. Neprilysin inhibition abolished these products and substantially reduced the overall metabolism of Ang-(1-12). Incubation of Ang-(1-12) with either human or mouse neprilysin revealed identical products. PMID:22490446
</p>
<p>Ang-(1-7) is the main metabolite of angiotensin I in rat hippocampi, and thimet oligopeptidase is the main enzyme involved in the generation of Ang-(1-7). PMID:24041943
</p>
<p>Metabolism of 125I-angiotensin I was investigated. In intact endothelial cells, production of Ang (1-7) was partially blocked by the addition of Z-pro-prolinal,  an inhibitor of prolyl endopeptidase. This confirms that prolyl endopeptidase is partially involved in the generation of Ang-(l-7). PMID:1310484
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re10">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:15283675" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re11">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10090" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:23392115" />
</rdf:Bag>
</bqbiol:isDescribedBy>
</rdf:Description>
<rdf:Description rdf:about="#re30">
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:15283675" />
</rdf:Bag>
</bqbiol:isDescribedBy>
</rdf:Description>
<rdf:Description rdf:about="#re123">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:22490446" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10116" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re133">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:24041943" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10116" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re134">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:1310484" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
artenobot's avatar
artenobot committed
1097
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa25"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa79" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa25_in_0" /><qual:input qual:qualitativeSpecies="sa70" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa25_in_1" /><qual:input qual:qualitativeSpecies="sa23" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa25_in_2" /><qual:input qual:qualitativeSpecies="sa51" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa25_in_3" /><qual:input qual:qualitativeSpecies="sa24" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa25_in_4" /><qual:input qual:qualitativeSpecies="sa22" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa25_in_5" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa25" qual:transitionEffect="assignmentLevel" qual:id="tr_sa25_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><or /><apply><and /><apply><eq /><ci>sa79</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa70</ci><cn type="integer">1</cn></apply></apply><apply><and /><apply><or /><apply><eq /><ci>sa23</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa51</ci><cn type="integer">1</cn></apply></apply><apply><eq /><ci>sa79</ci><cn type="integer">1</cn></apply></apply><apply><and /><apply><eq /><ci>sa79</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa24</ci><cn type="integer">1</cn></apply></apply><apply><and /><apply><eq /><ci>sa79</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa22</ci><cn type="integer">1</cn></apply></apply></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>Although treatment with AGTR1 antagonist (losartan) or AGTR2 agonist (CGP42112A) inhibits tumor progression in several cancer cells, their combined treatment has not been reported. PMID:25014541
artenobot's avatar
artenobot committed
1098
1099
1100
1101
1102
1103
1104
1105
1106
1107
1108
1109
1110
1111
1112
1113
1114
1115
1116
1117
1118
1119
1120
1121
1122
1123
1124
1125
1126
1127
1128
1129
1130
1131
1132
1133
1134
1135
1136
1137
1138
1139
1140
1141
1142
1143
1144
1145
1146
1147
1148
1149
1150
1151
1152
1153
1154
1155
1156
1157
1158
1159
1160
1161
</p>
<p>Angiotensin II (ANGII) signaling, mediated via angiotensin II receptor type 1 (AGTR1) or type 2 (AGTR2), controls tissue remodeling in fibrosis, but the relevance of AGTR2 remains elusive. PMID:17630322
Chronic activation of the myocardial renin angiotensin system (RAS) elevates the local level of angiotensin II (Ang II) thereby inducing pathological cardiac hypertrophy, which contributes to heart failure. The authors report a novel paracrine mechanism between cardiac fibroblasts (CF)s and cardiomyocytes whereby Ang II induces pathological cardiac hypertrophy. In cultured rat CFs, Ang II treatment enhanced exosome release via the activation of Ang II receptor types 1 (AT1R) and 2 (AT2R), whereas lipopolysaccharide, insulin, endothelin (ET)-1, transforming growth factor beta (TGFbeta)1 or hydrogen peroxide did not. PMID:26497614
ANG (1-7) acts primarily via the G protein-coupled receptor MAS1, and forms ANG (1-5), which signals via MRGPRD. ANG (1-7) can also act via the AGTR2 receptor but with much lower affinity than ANG II. PMID:32333398
Ang A has the same affinity to the AT1 receptor as Ang II, but a higher affinity to the AT2 receptor. PMID:17138938
</p>
<p>ANG (1-7) acts primarily via the G protein-coupled receptor MAS1, and forms ANG (1-5), which signals via MRGPRD. ANG (1-7) can also act via the AGTR2 receptor but with much lower affinity than ANG II. PMID:32333398
The study investigated whether a vasodepressor effect of Ang-(1-7) could be unmasked acutely in conscious spontaneously hypertensive rats (SHR) against a background of angiotensin II type 1 (AT1) receptor blockade. Mean arterial pressure (MAP) and heart rate were measured over a 5-day protocol in various groups of rats randomized to receive the following drug combinations: saline, AT1 receptor (AT1R) antagonist candesartan (0.01 or 0.1 mg/kg IV) alone, Ang-(1-7) (5 pmol/min) alone, candesartan plus Ang-(1-7), and candesartan plus Ang-(1-7) and angiotensin II type 2 (AT2) receptor (AT2R) antagonist PD123319 (50 microg/kg per minute). In Wistar-Kyoto (WKY) rats, saline, Ang-(1-7), or candesartan alone caused no significant alteration in MAP, whereas Ang-(1-7) coadministered with candesartan caused a marked, sustained reduction in MAP. A similar unmasking of a vasodepressor response to Ang-(1-7) during AT1R blockade was observed in SHR. Moreover, the AT(2)R antagonist PD123319 markedly attenuated the enhanced depressor response evoked by the Ang-(1-7)/candesartan combination in SHR and WKY rats. In separate experiments, the bradykinin type 2 receptor antagonist HOE 140 (100 microg/kg IV) or the NO synthase inhibitor Nomega-nitro-L-arginine methyl ester (1 mg/kg IV) abolished the depressor effect of Ang-(1-7) in the presence of candesartan. Collectively, these results suggest that Ang-(1-7) evoked a depressor response during AT1R blockade via activation of AT2R, which involves the bradykinin-NO cascade. PMID:15767466
</p>
<p>Systemic delivery of angiotensin-(1-9) significantly decreased cell death and improved left ventricular recovery after in vivo myocardial infarction. In vitro, angiotensin-(1-9) decreased cell death in isolated neonatal rat ventricular cardiomyocytes subjected to simulated ischemia/reperfusion. The cardioprotective effects of angiotensin-(1-9) were blocked by PD123319 (AT2R antagonist) and Akt inhibitor but not by A779 (Mas antagonist). Angiotensin-(1-9) limits reperfusion-induced cell death by an AT2R- and Akt-dependent mechanism. PMID:30048754
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re67">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:25014541" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re81">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:17630322" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:17138938" />
</rdf:Bag>
</bqbiol:isDescribedBy>
</rdf:Description>
<rdf:Description rdf:about="#re138">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:15767466" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10116" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re139">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:30048754" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10116" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
artenobot's avatar
artenobot committed
1162
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa27"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa77" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa27_in_0" /><qual:input qual:qualitativeSpecies="sa32" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa27_in_1" /><qual:input qual:qualitativeSpecies="sa159" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa27_in_2" /><qual:input qual:qualitativeSpecies="sa24" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa27_in_3" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa27" qual:transitionEffect="assignmentLevel" qual:id="tr_sa27_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><or /><apply><and /><apply><eq /><ci>sa77</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa32</ci><cn type="integer">1</cn></apply></apply><apply><and /><apply><eq /><ci>sa77</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa159</ci><cn type="integer">1</cn></apply></apply><apply><and /><apply><eq /><ci>sa77</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa24</ci><cn type="integer">1</cn></apply></apply></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>Angiotensin-(1-5) [Ang-(1-5)], which is a metabolite of Angiotensin-(1-7) [Ang-(1-7)] catalyzed by angiotensin-converting enzyme (ACE), is a pentapeptide of the renin-angiotensin system (RAS). It has been reported that Ang-(1-7) and Ang-(1-9) stimulate the secretion of atrial natriuretic peptide (ANP) via Mas receptor (Mas R) and Ang II type 2 receptor (AT2R), respectively. The effect of Ang-(1-5) on ANP secretion was investigated using isolated perfused beating rat atria. Ang-(1-5) stimulated high pacing frequency-induced ANP secretion in a dose-dependent manner. Ang-(1-5)-induced ANP secretion was attenuated by the pretreatment with an antagonist of Mas R (A-779) but not by an antagonist of AT1R (losartan) or AT2R (PD123,319). PMID:27660028
artenobot's avatar
artenobot committed
1163
1164
1165
1166
1167
1168
1169
1170
1171
1172
1173
1174
1175
1176
1177
1178
1179
1180
1181
1182
1183
1184
1185
1186
1187
1188
1189
1190
1191
1192
1193
1194
1195
1196
1197
1198
1199
1200
1201
1202
1203
1204
</p>
<p>In support of this hypothesis we show that the non-peptide MAS agonist AR234960 increases both mRNA and protein levels of CTGF via ERK1/2 signaling in HEK293-MAS cells and adult human cardiac fibroblasts. PMID:29287092
</p>
<p>ANG-(1-7) itself acts on the receptor MAS to influence a range of mechanisms in the heart, kidney, brain, and other tissues. PMID:29351514
Angiotensin (Ang)-(1-7) has cardiovascular protective effects and is the opponent of the often detrimental Ang II within the renin-angiotensin system. The study aimed to identify a second messenger stimulated by Ang-(1-7) allowing confirmation as well as discovery of the heptapeptide's receptors. Ang-(1-7) elevates cAMP concentration in primary cells, such as endothelial or mesangial cells. Using cAMP as readout in receptor-transfected human embryonic kidney (HEK293) cells, the study provided pharmacological proof that Mas is a functional receptor for Ang-(1-7). Moreover, the authors identified the G-protein-coupled receptor MrgD as a second receptor for Ang-(1-7). PMID:27217404
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re42">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:27660028" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10116" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re127">
<bqmodel:is>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:29287092" />
</rdf:Bag>
</bqmodel:is>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re140">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:27217404" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
cylon-x's avatar
cylon-x committed
1205
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa28"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa37" qual:transitionEffect="none" qual:sign="negative" qual:id="tr_sa28_in_0" /><qual:input qual:qualitativeSpecies="sa169" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa28_in_1" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa28" qual:transitionEffect="assignmentLevel" qual:id="tr_sa28_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><and /><apply><eq /><ci>sa169</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa37</ci><cn type="integer">0</cn></apply></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>Addition of estradiol (E2) to HUVEC cells induces a concentration-dependent increase of ACE1 and ACE2 mRNA expression and ACE1, but not ACE2, protein levels. ACE1 and ACE2 enzymatic activities are also induced with E2. These effects were mediated through estrogen receptor alpha activation, since ER antagonists ICI 182780 and MPP completely abolishes the effect of E2. PMID:26562171
artenobot's avatar
artenobot committed
1206
Calcitriol inhibits ACE and AT1R expression, and induces ACE2 expression in LPS-treated rat PMVECs. PMID:28944831
artenobot's avatar
artenobot committed
1207
</p>
artenobot's avatar
artenobot committed
1208
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re197">
artenobot's avatar
artenobot committed
1209
1210
<bqbiol:isDescribedBy>
<rdf:Bag>
artenobot's avatar
artenobot committed
1211
1212
1213
1214
1215
1216
1217
1218
1219
1220
1221
<rdf:li rdf:resource="urn:miriam:pubmed:26562171" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:28944831" />
artenobot's avatar
artenobot committed
1222
1223
1224
1225
1226
1227
1228
1229
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10116" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
artenobot's avatar
artenobot committed
1230
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa30"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa168" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa30_in_0" /><qual:input qual:qualitativeSpecies="sa169" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa30_in_1" /><qual:input qual:qualitativeSpecies="sa38" qual:transitionEffect="none" qual:sign="negative" qual:id="tr_sa30_in_2" /><qual:input qual:qualitativeSpecies="sa201" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa30_in_3" /><qual:input qual:qualitativeSpecies="sa165" qual:transitionEffect="none" qual:sign="negative" qual:id="tr_sa30_in_4" /><qual:input qual:qualitativeSpecies="sa54" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa30_in_5" /><qual:input qual:qualitativeSpecies="sa202" qual:transitionEffect="none" qual:sign="negative" qual:id="tr_sa30_in_6" /><qual:input qual:qualitativeSpecies="sa203" qual:transitionEffect="none" qual:sign="negative" qual:id="tr_sa30_in_7" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa30" qual:transitionEffect="assignmentLevel" qual:id="tr_sa30_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><or /><apply><and /><apply><or /><apply><eq /><ci>sa169</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa201</ci><cn type="integer">1</cn></apply></apply><apply><eq /><ci>sa168</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa38</ci><cn type="integer">0</cn></apply></apply><apply><eq /><ci>sa165</ci><cn type="integer">0</cn></apply><apply><and /><apply><eq /><ci>sa168</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa54</ci><cn type="integer">1</cn></apply></apply><apply><and /><apply><eq /><ci>sa168</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa202</ci><cn type="integer">0</cn></apply><apply><eq /><ci>sa203</ci><cn type="integer">0</cn></apply></apply></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>Human bronchial epithelial cells treated with 17-beta-estradiol (E2), expressed lower levels of ACE2 mRNA compared with the vehicle-treated controls. The levels of TMPRSS2 mRNA were not affected by E2 treatment. PMID:32432918
artenobot's avatar
artenobot committed
1231
1232
1233
1234
1235
1236
1237
1238
1239
1240
1241
1242
Addition of estradiol (E2) to HUVEC cells induces a concentration-dependent increase of ACE1 and ACE2 mRNA expression and ACE1, but not ACE2, protein levels. ACE1 and ACE2 enzymatic activities are also induced with E2. These effects were mediated through estrogen receptor alpha activation, since ER antagonists ICI 182780 and MPP completely abolishes the effect of E2. PMID:26562171
Calcitriol inhibits ACE and AT1R expression, and induces ACE2 expression in LPS-treated rat PMVECs. PMID:28944831
Recombinant SARS-CoV spike protein downregulates ACE2 expression and thereby promotes lung injury. PMID:19864379
</p>
<p>By using quantitative translatome and proteomics the authors found that the protein level of ACE2 is mildly reduced after infection. PMID:32408336
</p>
<p>We found age-dependent ACE2 gene expression in nasal epithelium. ACE2 gene expression was lowest (mean log2 counts per million, 2.40; 95% CI, 2.07-2.72) in younger children (n = 45) and increased with age, with mean log2 counts per million of 2.77 (95% CI, 2.64-2.90) for older children (n = 185), 3.02 (95% CI, 2.78-3.26) for young adults (n = 46), and 3.09 (95% CI, 2.83-3.35) for adults (n = 29). PMID:32432657
</p>
<p>The present study explored the signaling mechanism by which ACE2 is regulated under hypertensive conditions. Real-time PCR and immunohistochemistry showed that ACE2 mRNA and protein expression levels were high, whereas ACE expression levels were moderate in both normal kidney and heart. In contrast, patients with hypertension showed marked ACE up-regulation and ACE2 down-regulation in both hypertensive cardiopathy and, particularly, hypertensive nephropathy. PMID:18403595
ACE2 and ACE mRNA levels were measured by real-time PCR in laser microdissected renal biopsies from 13 diabetic and 8 control patients. ACE2 mRNA was significantly reduced by more than half in both the glomeruli and proximal tubules of the diabetic patients compared to controls, but ACE mRNA was increased in both compartments. PMID:19034303
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re153">
artenobot's avatar
artenobot committed
1243
1244
1245
1246
1247
1248
1249
1250
1251
1252
1253
1254
1255
1256
1257
1258
1259
1260
1261
1262
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:32432918" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:19864379" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:uniprot:P59594" />
</rdf:Bag>
</bqbiol:isEncodedBy>
artenobot's avatar
artenobot committed
1263
1264
1265
1266
1267
1268
1269
1270
1271
1272
1273
1274
1275
1276
1277
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:26562171" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:28944831" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10116" />
</rdf:Bag>
</bqbiol:isEncodedBy>
artenobot's avatar
artenobot committed
1278
1279
1280
1281
1282
1283
1284
1285
1286
1287
1288
1289
1290
</rdf:Description>
<rdf:Description rdf:about="#re168">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:32408336" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
artenobot's avatar
artenobot committed
1291
1292
1293
1294
1295
1296
1297
1298
1299
1300
1301
1302
1303
1304
1305
1306
1307
1308
1309
1310
1311
1312
1313
1314
1315
1316
1317
1318
1319
<rdf:Description rdf:about="#re189">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:32432657" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re200">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:18403595" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:19034303" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
artenobot's avatar
artenobot committed
1320
1321
1322
1323
1324
1325
1326
1327
1328
1329
1330
1331
1332
1333
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa32"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa24" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa32_in_0" /><qual:input qual:qualitativeSpecies="sa100" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa32_in_1" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa32" qual:transitionEffect="assignmentLevel" qual:id="tr_sa32_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><and /><apply><eq /><ci>sa24</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa100</ci><cn type="integer">1</cn></apply></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>Incubation of Ang1-9 with ACE in vitro generated Ang1-7 and Ang1-5, apparently by sequential cleavage of C-terminal dipeptides. PMID:10969042
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#CDMT00034">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:10969042" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
artenobot's avatar
artenobot committed
1334
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa34"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa134" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa34_in_0" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa34" qual:transitionEffect="assignmentLevel" qual:id="tr_sa34_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><eq /><ci>sa134</ci><cn type="integer">1</cn></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>The effects of ethynylestradiol (EE) on liver AOG mRNA and plasma AOG has been tested in intact male and ovariectomized female rats, as well as in hypophysectomized male rats. EE stimulated both variables to a comparable extent and in a dose-dependent manner. However, its effect on plasma AOG was significantly higher in female than in male rats. PMID:8351287
artenobot's avatar
artenobot committed
1335
</p>
artenobot's avatar
artenobot committed
1336
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re167">
artenobot's avatar
artenobot committed
1337
1338
<bqbiol:isDescribedBy>
<rdf:Bag>
artenobot's avatar
artenobot committed
1339
<rdf:li rdf:resource="urn:miriam:pubmed:8351287" />
artenobot's avatar
artenobot committed
1340
1341
1342
1343
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
artenobot's avatar
artenobot committed
1344
<rdf:li rdf:resource="urn:miriam:taxonomy:10116" />
artenobot's avatar
artenobot committed
1345
1346
1347
1348
1349
1350
1351
1352
1353
1354
1355
1356
1357
1358
1359
1360
1361
1362
1363
1364
1365
1366
1367
1368
1369
1370
1371
1372
1373
1374
1375
1376
1377
1378
1379
1380
1381
1382
1383
1384
1385
1386
1387
1388
1389
1390
1391
1392
1393
1394
1395
1396
1397
1398
1399
1400
1401
1402
1403
1404
1405
1406
1407
1408
1409
1410
1411
1412
1413
1414
1415
1416
1417
1418
1419
1420
1421
1422
1423
1424
1425
1426
1427
1428
1429
1430
1431
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa40"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa132" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa40_in_0" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa40" qual:transitionEffect="assignmentLevel" qual:id="tr_sa40_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><eq /><ci>sa132</ci><cn type="integer">1</cn></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>The expression level of TMPRSS2 increased 6-fold in androgen stimulated LNCaP cells. PMID:10485450
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re112">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:10485450" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa49"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa24" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa49_in_0" /><qual:input qual:qualitativeSpecies="sa51" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa49_in_1" /><qual:input qual:qualitativeSpecies="sa30" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa49_in_2" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa49" qual:transitionEffect="assignmentLevel" qual:id="tr_sa49_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><or /><apply><eq /><ci>sa24</ci><cn type="integer">1</cn></apply><apply><and /><apply><eq /><ci>sa51</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa30</ci><cn type="integer">1</cn></apply></apply></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>Ang-(1–7) can be processed to alamandine in the isolated rat heart. PMID:23446738
</p>
<p>Using mass spectrometry the authors identified alamandine as a product of the catalytic hydrolysis of the octapeptide Ala1-AngII (angiotensin A) by human ACE2. They demonstrate that alamandine can be formed in the rat heart after Ang-(1–7) perfusion with the use of selected  reaction  monitoring-mass  spectrometry. This indicates that the cardiac tissue contains all necessary components to promote the decarboxylation of the Ang-(1–7) N-terminal aspartate amino acid residue. The sequence of alamandine is very similar to Ang-(1–7), differing only by the presence of an alanine residue in place of an aspartate residue in the amino terminus. PMID:23446738
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re43">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:23446738" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10116" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re46">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:23446738" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa50"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa94" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa50_in_0" /><qual:input qual:qualitativeSpecies="sa49" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa50_in_1" /><qual:input qual:qualitativeSpecies="sa24" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa50_in_2" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa50" qual:transitionEffect="assignmentLevel" qual:id="tr_sa50_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><or /><apply><and /><apply><eq /><ci>sa94</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa49</ci><cn type="integer">1</cn></apply></apply><apply><and /><apply><eq /><ci>sa94</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa24</ci><cn type="integer">1</cn></apply></apply></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>To further address the role of MrgD in the alamandine effects, binding and functional studies in human MrgD-transfected cells were performed. Fluorescent-labeled alamandine specifically binds to MrgD-stably CHO cells transfected with human proteins. PMID:23446738
</p>
<p>Angiotensin (Ang)-(1-7) has cardiovascular protective effects and is the opponent of the often detrimental Ang II within the renin-angiotensin system. The study aimed to identify a second messenger stimulated by Ang-(1-7) allowing confirmation as well as discovery of the heptapeptide's receptors. Ang-(1-7) elevates cAMP concentration in primary cells, such as endothelial or mesangial cells. Using cAMP as readout in receptor-transfected human embryonic kidney (HEK293) cells, the study provided pharmacological proof that Mas is a functional receptor for Ang-(1-7). Moreover, the authors identified the G-protein-coupled receptor MrgD as a second receptor for Ang-(1-7). PMID:27217404
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re90">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:23446738" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re141">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:27217404" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa51"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa23" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa51_in_0" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa51" qual:transitionEffect="assignmentLevel" qual:id="tr_sa51_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><eq /><ci>sa23</ci><cn type="integer">1</cn></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>Chromatographic purification and structural analysis by matrix-assisted laser desorption/ionisation time-of-flight/time-of-flight (MALDI-TOF/TOF) revealed an angiotensin octapeptide with the sequence Ala-Arg-Val-Tyr-Ile-His-Pro-Phe, which differs from Ang II in Ala1 instead of Asp1. Des[Asp1]-[Ala1]-Ang II, in the following named Angiotensin A (Ang A), is most likely generated enzymatically. In the presence of mononuclear leukocytes, Ang II is converted to Ang A by decarboxylation of Asp1. PMID:17138938
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re45">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:17138938" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
artenobot's avatar
artenobot committed
1432
1433
1434
1435
1436
1437
1438
1439
1440
1441
1442
1443
1444
1445
1446
1447
1448
1449
1450
1451
1452
1453
1454
1455
1456
1457
1458
1459
1460
1461
1462
1463
1464
1465
1466
1467
1468
1469
1470
1471
1472
1473
1474
1475
1476
1477
1478
1479
1480
1481
1482
1483
1484
1485
1486
1487
1488
1489
1490
1491
1492
1493
1494
1495
1496
1497
1498
1499
1500
1501
1502
1503
1504
1505
1506
1507
1508
1509
1510
1511
1512
1513
1514
1515
1516
1517
1518
1519
1520
1521
1522
1523
1524
1525
1526
1527
1528
1529
1530
1531
1532
1533
1534
1535
1536
1537
1538
1539
1540
1541
1542
1543
1544
1545
1546
1547
1548
1549
1550
1551
1552
1553
1554
1555
1556
1557
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa56"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa25" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa56_in_0" /><qual:input qual:qualitativeSpecies="sa27" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa56_in_1" /><qual:input qual:qualitativeSpecies="sa156" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa56_in_2" /><qual:input qual:qualitativeSpecies="sa50" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa56_in_3" /><qual:input qual:qualitativeSpecies="sa102" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa56_in_4" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa56" qual:transitionEffect="assignmentLevel" qual:id="tr_sa56_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><or /><apply><eq /><ci>sa25</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa27</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa156</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa50</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa102</ci><cn type="integer">1</cn></apply></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>AT2R is involved in vasodilatation and regulates pancreas development. PMID:30404071
</p>
<p>Mas-deficient aortas lose their Ang-(1-7)-induced relaxation response. PMID:12829792
</p>
<p>AngIV-binding at AT4 sites causes a vasodilatory effect probably via endothelial cell release of NO. Originally identified as endothelium-derived  relaxing  factor, NO is released by vascular endothelial cells and smooth muscle cells. NO release leads to an increase in cGMP production and vasodilation. PMID:9493859
</p>
<p>As previously reported for angiotensin (1-7), alamandine produces endothelial-dependent vasorelaxation in aortic rings from FVB/N mice. Similar data were obtained in aortic rings from Wistar rats. D-Pro7-Ang-(1–7) completely blocked the vasorelaxation produced by alamandine in mice aortic rings. The data reveal that its actions are independent of the known vasodilator receptors of the RAS, Mas, and angiotensin II type 2 receptor. The authors demonstrate that alamandine acts through the Mas-related G-protein-coupled receptor, member D. PMID:23446738
</p>
<p>ANG2 interaction with AT1R leads to vasoconstriction, cell growth, inflammation, fibrosis and oxidative stress. PMID:30404071
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re77">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:30404071" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:40674" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re142">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:12829792" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10090" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re145">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:9493859" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10116" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re146">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:23446738" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10090" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re183">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:30404071" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:40674" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa61"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa50" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa61_in_0" /><qual:input qual:qualitativeSpecies="sa27" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa61_in_1" /><qual:input qual:qualitativeSpecies="sa156" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa61_in_2" /><qual:input qual:qualitativeSpecies="sa102" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa61_in_3" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa61" qual:transitionEffect="assignmentLevel" qual:id="tr_sa61_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><or /><apply><eq /><ci>sa50</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa27</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa156</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa102</ci><cn type="integer">1</cn></apply></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>The study evaluated the effects of angiotensin-(1-7) (Ang-(1-7)) and the novel renin-angiotensin system (RAS) peptide, alamandine, on resting (M0), proinflammatory M(LPS+IFN-gamma), and anti-inflammatory M(IL-4) macrophage phenotypes in vitro, as well as on specific immune cell populations and macrophage subsets into the pleural cavity of LPS-induced pleurisy in mice. The results showed that Ang-(1-7) and alamandine, through Mas and MrgD receptors, respectively, do not affect M0 macrophages but reduce the proinflammatory TNF-alpha, CCL2, and IL-1beta transcript expression levels in LPS+IFN-gamma-stimulated macrophages. PMID:30918468
</p>
<p>The study evaluated the effects of angiotensin-(1-7) (Ang-(1-7)) and the novel renin-angiotensin system (RAS) peptide, alamandine, on resting (M0), proinflammatory M(LPS+IFN-gamma), and anti-inflammatory M(IL-4) macrophage phenotypes in vitro, as well as on specific immune cell populations and macrophage subsets into the pleural cavity of LPS-induced pleurisy in mice. The results showed that Ang-(1-7) and alamandine, through Mas and MrgD receptors, respectively, do not affect M0 macrophages but reduce the proinflammatory TNF-alpha, CCL2, and IL-1beta transcript expression levels in LPS+IFN-gamma-stimulated macrophages. PMID:30918468
</p>
<p>Angiotensin IV protects cardiac reperfusion injury by inhibiting apoptosis and inflammation via AT4R in rats. PMID:27038740
</p>
<p>ANG2 interaction with AT1R leads to vasoconstriction, cell growth, inflammation, fibrosis and oxidative stress. PMID:30404071
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re74">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:30918468" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10090" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re75">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:30918468" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10090" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re144">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:27038740" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10116" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
<rdf:Description rdf:about="#re181">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:30404071" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:40674" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
artenobot's avatar
artenobot committed
1558
1559
1560
1561
1562
1563
1564
1565
1566
1567
1568
1569
1570
1571
1572
1573
1574
1575
1576
1577
1578
1579
1580
1581
1582
1583
1584
1585
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa62"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa23" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa62_in_0" /><qual:input qual:qualitativeSpecies="sa64" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa62_in_1" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa62" qual:transitionEffect="assignmentLevel" qual:id="tr_sa62_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><and /><apply><eq /><ci>sa23</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa64</ci><cn type="integer">1</cn></apply></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>Mice received Ang II intracerebroventricularly in the presence or absence of the aminopeptidase A (APA) inhibitor, EC33 (3-amino-4-thio-butyl sulfonate) or of the aminopeptidase N (APN) inhibitor, EC27 (2-amino-pentan-1,5-dithiol). Ang II and Ang III levels were evaluated from hypothalamus homogenates by HPLC. EC33 increased the half-life of Ang II 2.6-fold and completely blocked the formation of Ang III, whereas EC27 increased the half-life of Ang III 2.3-fold. These results demonstrate that APA and APN are involved in vivo in the metabolism of brain Ang II and Ang III, respectively. PMID:8876246
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re61">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:8876246" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10090" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa63"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa62" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa63_in_0" /><qual:input qual:qualitativeSpecies="sa65" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa63_in_1" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa63" qual:transitionEffect="assignmentLevel" qual:id="tr_sa63_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><and /><apply><eq /><ci>sa62</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa65</ci><cn type="integer">1</cn></apply></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>Mice received Ang II intracerebroventricularly in the presence or absence of the aminopeptidase A (APA) inhibitor, EC33 (3-amino-4-thio-butyl sulfonate) or of the aminopeptidase N (APN) inhibitor, EC27 (2-amino-pentan-1,5-dithiol). Ang II and Ang III levels were evaluated from hypothalamus homogenates by HPLC. EC33 increased the half-life of Ang II 2.6-fold and completely blocked the formation of Ang III, whereas EC27 increased the half-life of Ang III 2.3-fold. These results demonstrate that APA and APN are involved in vivo in the metabolism of brain Ang II and Ang III, respectively. PMID:8876246
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re62">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:8876246" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10090" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
cylon-x's avatar
cylon-x committed
1586
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa64"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa162" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa64_in_0" /><qual:input qual:qualitativeSpecies="sa161" qual:transitionEffect="none" qual:sign="negative" qual:id="tr_sa64_in_1" /><qual:input qual:qualitativeSpecies="sa44" qual:transitionEffect="none" qual:sign="negative" qual:id="tr_sa64_in_2" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa64" qual:transitionEffect="assignmentLevel" qual:id="tr_sa64_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><or /><apply><and /><apply><eq /><ci>sa162</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa161</ci><cn type="integer">0</cn></apply></apply><apply><and /><apply><eq /><ci>sa162</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa44</ci><cn type="integer">0</cn></apply></apply></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>We demonstrated here the antihypertensive effects of RB150, a prodrug of the specific and selective aminopeptidase A inhibitor, EC33, in spontaneously hypertensive rats, a model of human essential hypertension. PMID:22710644
artenobot's avatar
artenobot committed
1587
</p>
artenobot's avatar
artenobot committed
1588
1589
1590
<p>Serum peptidases, such as angiotensin-converting enzyme (ACE), angiotensin-converting enzyme-2 (ACE2), neutral endopeptidase (NEP), aminopeptidase N (APN), and aminopeptidase A (APA), are important elements of the renin-angiotensin system (RAS). Dysregulation of these enzymes has been associated with hypertension and cardiovascular risk. In the present study, serum activities of RAS peptidases were analyzed to evaluate the existence of sexual differences, with a possible different pattern in pre- and post-andropausal/post-menopausal participants. Significantly lower serum APA activity was observed in men with respect to women; no sex differences were detected for ACE, ACE2, NEP, or APN. PMID:28174624
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re128">
artenobot's avatar
artenobot committed
1591
1592
<bqbiol:isDescribedBy>
<rdf:Bag>
artenobot's avatar
artenobot committed
1593
<rdf:li rdf:resource="urn:miriam:pubmed:22710644" />
artenobot's avatar
artenobot committed
1594
1595
1596
1597
1598
1599
1600
1601
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10116" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
artenobot's avatar
artenobot committed
1602
1603
1604
1605
1606
1607
1608
1609
1610
1611
1612
1613
<rdf:Description rdf:about="#re191">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:28174624" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:9606" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
artenobot's avatar
artenobot committed
1614
1615
1616
1617
1618
1619
1620
1621
1622
1623
1624
1625
1626
1627
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa71"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa37" qual:transitionEffect="none" qual:sign="negative" qual:id="tr_sa71_in_0" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa71" qual:transitionEffect="assignmentLevel" qual:id="tr_sa71_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><eq /><ci>sa37</ci><cn type="integer">0</cn></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>In wild-type mice, inhibition of 1,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)] synthesis also led to an increase in renin expression, whereas 1,25(OH)(2)D(3) injection led to renin suppression. PMID:12122115
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re21">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:12122115" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol:isEncodedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:taxonomy:10090" />
</rdf:Bag>
</bqbiol:isEncodedBy>
</rdf:Description>
cylon-x's avatar
cylon-x committed
1628
</rdf:RDF></annotation></qual:transition><qual:transition qual:id="tr_sa73"><qual:listOfInputs><qual:input qual:qualitativeSpecies="sa30" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa73_in_0" /><qual:input qual:qualitativeSpecies="sa43" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa73_in_1" /><qual:input qual:qualitativeSpecies="sa102" qual:transitionEffect="none" qual:sign="positive" qual:id="tr_sa73_in_2" /></qual:listOfInputs><qual:listOfOutputs><qual:output qual:qualitativeSpecies="sa73" qual:transitionEffect="assignmentLevel" qual:id="tr_sa73_out" /></qual:listOfOutputs><qual:listOfFunctionTerms><qual:defaultTerm qual:resultLevel="0" /><qual:functionTerm qual:resultLevel="1"><math xmlns="http://www.w3.org/1998/Math/MathML"><apply><and /><apply><or /><apply><eq /><ci>sa43</ci><cn type="integer">1</cn></apply><apply><eq /><ci>sa102</ci><cn type="integer">1</cn></apply></apply><apply><eq /><ci>sa30</ci><cn type="integer">1</cn></apply></apply></math></qual:functionTerm></qual:listOfFunctionTerms><notes><html xmlns="http://www.w3.org/1999/xhtml"><head><title /></head><body><p>ACE2, in particular its catalytic ectodomain, can be shed from cells into the circulation as soluble ACE2, an action mediated by the metalloprotease ADAM17, an activator of Notch pathway. PMID:32333398
artenobot's avatar
artenobot committed
1629
1630
1631
1632
1633
1634
1635
1636
1637
1638
1639
1640
1641
1642
1643
1644
1645
1646
1647
1648
1649
1650
1651
1652
1653
ADAM17, the ACE2 sheddase, requires arginine and lysine residues within ACE2 amino acids 652 to 659 for receptor cleavage and competes with TMPRSS2 for ACE2 processing. PMID:24227843
Angiotensin II type 1 receptors promote ADAM17-mediated ACE2 shedding in the brain of hypertensive patients, leading to a loss in compensatory activity during neurogenic hypertension. PMID:28512108
</p>
</body></html></notes><annotation><rdf:RDF><rdf:Description rdf:about="#re69">
<bqbiol:isDescribedBy>
<rdf:Bag>
<rdf:li rdf:resource="urn:miriam:pubmed:24227843" />
</rdf:Bag>
</bqbiol:isDescribedBy>
<bqbiol